The first webinar focuses on diseases originating from the B-cell lineage. Join Jennifer McCallister, an esteemed expert in the field, as she provides insights into the diagnosis of B-cell neoplasms.

They then examined how this affected different cell types, finding that the knockout negatively impacted HSCs and immune ...

The firm is also shuttering its allogeneic cell therapy platform and has tasked a new CEO to lead the company through a merger.